Treatment and outcomes in patients with asthma and allergic rhinitis in the United Kingdom

International Archives of Allergy and Immunology

Volumn 142, Issue 4, 2007, Pages 318-328

  Zhang, Qiaoyi ^a   Thomas, Michael ^c   Wisniewski, Tami ^b   Sazonov Kocevar, Vasilisa ^a   Price, David ^c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Allergic rhinitis; Asthma; Inhaled corticosteroids; Long acting agonists; Montelukast

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; LONG ACTING DRUG; MONTELUKAST; STEROID;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; COMBINATION CHEMOTHERAPY; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EVALUATION; FEMALE; GROUPS BY AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UNITED KINGDOM; UNIVARIATE ANALYSIS;

ACETATES; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; BUDESONIDE; COHORT STUDIES; COMORBIDITY; DRUG THERAPY, COMBINATION; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; QUINOLINES; RHINITIS; TREATMENT OUTCOME;

EID: 33947236982     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097501     Document Type: Article

References (46)

1. Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-478.
2. Gupta R, Sheikh A, Strachan DP, Anderson HR: Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004;34:520-526.
3. Masoli M, Fabian D, Holt S, Beasley R: Global Burden of Asthma Report. http://www.ginasthma.com/BackgroundersItem.asp?intId=19 (accessed May 3, 2006).
4. Sazonov Kocevar V, Ambegaonkar BM, Bolge SC, Radican FL: Allergic rhinitis neither routinely diagnosed nor treated in asthma patients. Eur Respir J 2005;26(suppl 49):249s.
5. Bauchau V, Durham SR: Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004;24:758-764.
6. Leynaert B, Neukirch F, Demoly P, Bousquet J: Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000;106(suppl 5):S201-S205.
7. Yawn BP, Yunginger JW, Wollan PC, Reed CE, Silverstein MD, Harris AG: Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol 1999;103(1 Pt 1):54-59.
8. Simons FER: What's in a name? The allergic rhinitis-asthma connection. Clin Exp Allergy Rev 2003;3:9-17.
9. Gaugris S, Sazonov Kocevar V, Thomas M: Burden of concomitant allergic rhinitis in adults with asthma. J Asthma 2006;43:1-7.
10. Price D, Zhang Q, Sazonov Kocevar V, Yin DD, Thomas M: Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy 2005;35:282-287.
11. Halpern MT, Schmier JK, Richner R, Guo C, Togias A: Allergic rhinitis: a potential cause of increased asthma medication use, costs, and morbidity. J Asthma 2004;41:117-126.
12. Bousquet J, Gaugris S, Sazonov Kocevar V, Zhang Q, Yin DD, Polos G, et al: Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial. Clin Exp Allergy 2005;35:723-727.
13. Katelaris CH: Allergic rhinitis and asthma: epidemiological evidence for the link. Clin Exp Allergy Rev 2003;3:5-8.
14. Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST: Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002;109:636-642.
15. Crystal-Peters J, Neslusan C, Crown WH, Torres A: Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002;109:57-62.
16. Corren J, Manning BE, Thompson SF, Hennessy S, Strom BL: Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol 2004;113:415-419.
17. Nathan RA, Yancey SW, Waitkus-Edwards K, Prillaman BA, Stauffer JL, Philpot E, Dorinsky PM, Nelson HS: Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest 2005;128:1910-1920.
18. Dahl R, Nielsen LP, Kips J, Foresi A, van Cauwenberge P, Tudoric N, Howarth P, Richards DH, Williams M, Pauwels R; SPIRA Study Group: Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. Allergy 2005;60:875-881.
19. Members of the Workshops: ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma. Allergy 2004;59:373-387.
20. Philip G, Nayak AS, Berger WE, Leynadier F, Vrijens F, Dass SB, et al: The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004;20:1549-1558.
21. Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S, Rojas R, van Noord JA, Pons M, Gilles L, Leff JA: Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003;58:211-216.
22. Lawrenson RA, Coles G, Walton K, Farmer RDT: Characteristics of practices contributing to the MediPlus database and the implications for its use in epidemiological research. J Inform Prim Care 1998;May:14-18.
23. Global Strategy for Asthma Management and Prevention. Update from NHLB/WHO Workshop Report 1995. NIH Publication No. 02-3659. Global Initiative for Asthma (GINA), 2002.
24. Leidy NK, Paramore LC, Wartrous M, Doyle J, Zeiger RS: Development of algorithm for scoring severity of asthma in administrative databases. Value Health 1999;2:394.
25. Luskin A, Bukstein D, Sazonov Kocevar V, Yin DD: Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy. Ann Allergy Asthma Immunol 2005;95:129-136.
26. Bjermer L, Bisgaard H, Bousquet J, et al: Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 2003;327:891-896.
27. Vaquerizo MJ, Casan P, Castillo J, Perpina M, Sanchis J, Sobradillo V, Valencia A, Verea H, Viejo JL, Villasante C, Gonzalez-Esteban J, Picado C; CASIOPEA (Capacidad de Singulair Oral en la Prevencion de Exacerbaciones Asmaticas) Study Group: Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 2003;58:204-210.
28. Price DB, Swern AS, Tozzi CA, Philip G, Polos P: Additional benefit of montelukast for asthma in patients with both asthma and allergic rhinitis: analysis from the COMPACT trial. Asthma 2006;61:737-742.
29. Philip G, Tozzi C, Reiss T: Efficacy of montelukast for asthma in patients with asthma and concomitant allergic rhinitis. Allergy Clin Immunol Int 2005;17(suppl 1):112.
30. Philip G, Vrijens F, Leynadier F, Reiss T: Efficacy of montelukast in patients with concomitant asthma and seasonal allergic rhinitis (SAR). Allergy Clin Immunol Int 2005;17(suppl 1):51.
31. Travier N, Sazonov Kocevar V, Yin DD, Laforest L, Van Ganse E: Rescue/acute and allergy medication use among children on asthma controller therapy (P2353). Eur Respir J 2004;24(suppl 48):378S.
32. Travier N, Sazonov Kocevar V, Yin DD, Laforest L, Van Ganse E: Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy (P2165). Eur Respir J 2004;24(suppl 48):344S.
33. Davies G, Dasbach E, Santanello N, Knorr B, Bratton D: The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma. Clin Ther 2004;26:1895-2004.
34. Stempel D, O'Donnell J, Meyer J: Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs. J Allergy Clin Immunol 2002;109:433-439.
35. Anstatt D, Allen-Ramey FC, Korelitz JJ, Bethel J, Sajjan S, Markson LE: Asthma control with montelukast or salmeterol as addon therapy to inhaled corticosteroid treatment of asthma. Chest 2003;124:94S.
36. Price D, Wolfe S: Montelukast: clinical and cost effectiveness in primary care. Am J Respir Crit Care Med 1999;159:A 640.
37. Price DB, Ben-Joseph RH, Zhang Q: Changes in asthma drug therapy costs for patients receiving chronic montelukast therapy in the U.K. Respir Med 2001;95:83-89.
38. Sturkenboom MCJM, Picelli G, Scamarcia A, Cantarutti L, Sazonov Kocevar V, Baraldi E, Giaquinto C: Asthma exacerbations in children receiving montelukast vs. other controllers in Italy (P3932). Eur Respir J 2005;26(suppl 49):618s.
39. Borderias L, Mincewicz G, Paggiaro P, Guilera M, Sazonov Kocevar V, Badia X: Improvement in asthma control and reduction in medical resource use following treatment with montelukast (PRAACTICAL Study). Eur Respir J 2005;26(suppl 49):576s.
40. Dal Negro R, Piskorz P, Vives Conesa R, Guilera M, Sazonov Kocevar V, Badia X: Reduction in asthma-related costs following treatment with montelukast (PRAACTICAL Study). Eur Respir J 2005;26(suppl 49):577s.
41. Guide to Clinical Preventative Services: Report of the US Preventive Services Task Force, ed 3. Baltimore, Lippincott Williams and Wilkins, 2005.
42. Bauman L, Wright E, Leickly F, et al: Relationship of adherence to pediatric asthma morbidity among inner-city children. Pediatrics 2002;110:e6.
43. Thomas M, Leather D, Price D: High-dose inhaled corticosteroids and add-on therapy use in adults with asthma in the UK in 2003: an observational study. Prim Care Respir J 2006;15:166-172.
44. Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: Methods, validity, and applications. J Clin Epidemiol 1997;50:105-116.
45. Bender B, Sazonov Kocevar V, Ambegaonkar BM, Bolge SC, Radican FL: Adherence to asthma treatment (impact of oral vs. inhaled treatment delivery on patient adherence to asthma controller medication); in Harver A, Kotses H (eds): Asthma, Health, and Society: From the Clinic to the Public. New York, Springer Publishing Co. In press.
46. Vollmer WM, Markson LE, O'Connor E, et al: Association of asthma control with health care utilization. Am J Respir Crit Care Med 2002;165:195-199.